UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000011630
Receipt number R000011778
Scientific Title THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0.6 mg/kg (THAWS) Trial
Date of disclosure of the study information 2013/09/09
Last modified on 2020/12/15 10:43:19

No. Disposal Last modified on Item of update
1 Insert 2013/09/02 19:14:24
2 Update 2013/09/06 10:50:35 Randomization unit
Blinding
3 Update 2013/09/06 10:51:58 Key secondary outcomes
4 Update 2013/09/06 10:54:53 Nationality of Funding Organization
Nationality of Funding Organization
Institutions
5 Update 2013/09/06 11:17:07 Institutions
6 Update 2015/01/16 11:21:00 Homepage URL
7 Update 2015/01/19 13:11:27 Recruitment status
Last follow-up date
URL releasing protocol
8 Update 2015/01/19 13:18:55 Institutions
9 Update 2015/01/19 13:20:02 Public title
10 Update 2015/01/19 13:20:38 Anticipated trial start date
11 Update 2015/01/19 16:18:24 Institutions
12 Update 2015/01/27 17:53:08 Institutions
13 Update 2015/09/01 10:43:47 Key inclusion criteria
Key inclusion criteria
14 Update 2015/09/01 10:49:46 Organization
Organization
Category of Funding Organization
Name of secondary funder(s)
Name of secondary funder(s)
15 Update 2015/09/01 12:47:11 Name of secondary funder(s)
Name of secondary funder(s)
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Institutions
16 Update 2015/10/02 16:59:22 Email1
17 Update 2017/11/01 08:55:28 Last follow-up date
URL related to results and publications
Results
18 Update 2018/03/07 11:36:02 Name of primary person or sponsor
Organization
Category of Funding Organization
19 Update 2018/03/07 11:40:51 Results
Results
20 Update 2018/03/07 11:51:13 Institutions
21 Update 2018/03/07 12:00:56 UMIN ID1
22 Update 2018/04/24 16:56:23 Key secondary outcomes
23 Update 2018/04/24 16:56:54 Results
Results
24 Update 2018/04/24 17:08:57 Key secondary outcomes
25 Update 2018/05/08 14:34:48 Key secondary outcomes
26 Update 2018/09/11 12:42:03 Key secondary outcomes
Key secondary outcomes
27 Update 2018/09/11 12:43:21 Recruitment status
Results
Results
28 Update 2019/03/05 09:18:06 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
29 Update 2019/03/05 12:11:01 Date trial data considered complete
Date analysis concluded
30 Update 2019/03/05 22:50:52 Last follow-up date
Date of closure to data entry
31 Update 2019/03/11 20:23:14 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Division name
Division name
Zip code
Organization
Organization
Address
Address
Tel
Email
32 Update 2019/03/11 20:24:58 Date of IRB
33 Update 2019/03/11 20:25:55 Number of participants that the trial has enrolled
Results date posted
34 Update 2019/03/13 09:33:01 Recruitment status
35 Update 2020/08/18 10:57:07 Publication of results
Results
Results
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
36 Update 2020/12/15 10:43:19 Other related information
Other related information